These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 27492962)

  • 1. Vonoprazan is superior to proton pump inhibitors in healing artificial ulcers of the stomach post-endoscopic submucosal dissection: A propensity score-matching analysis.
    Maruoka D; Arai M; Kasamatsu S; Ishigami H; Taida T; Okimoto K; Saito K; Matsumura T; Nakagawa T; Katsuno T; Yokosuka O
    Dig Endosc; 2017 Jan; 29(1):57-64. PubMed ID: 27492962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of vonoprazan on the treatment of artificial gastric ulcers after endoscopic submucosal dissection: Prospective randomized controlled trial.
    Tsuchiya I; Kato Y; Tanida E; Masui Y; Kato S; Nakajima A; Izumi M
    Dig Endosc; 2017 Jul; 29(5):576-583. PubMed ID: 28267236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized Controlled Trial Comparing the Effects of Vonoprazan Plus Rebamipide and Esomeprazole Plus Rebamipide on Gastric Ulcer Healing Induced by Endoscopic Submucosal Dissection.
    Ichida T; Ueyama S; Eto T; Kusano F; Sakai Y
    Intern Med; 2019 Jan; 58(2):159-166. PubMed ID: 30210115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective randomized trial of a potassium competitive acid blocker vs proton pump inhibitors on the effect of ulcer healing after endoscopic submucosal dissection of gastric neoplasia.
    Komori H; Ueyama H; Nagahara A; Akazawa Y; Takeda T; Matsumoto K; Matsumoto K; Asaoka D; Hojo M; Yao T; Watanabe S
    J Int Med Res; 2019 Apr; 47(4):1441-1452. PubMed ID: 30816056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vonoprazan prevents bleeding from endoscopic submucosal dissection-induced gastric ulcers.
    Kagawa T; Iwamuro M; Ishikawa S; Ishida M; Kuraoka S; Sasaki K; Sakakihara I; Izumikawa K; Yamamoto K; Takahashi S; Tanaka S; Matsuura M; Hasui T; Wato M; Inaba T
    Aliment Pharmacol Ther; 2016 Sep; 44(6):583-91. PubMed ID: 27464849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term efficacy of potassium-competitive acid blocker following gastric endoscopic submucosal dissection: a propensity score analysis.
    Horikawa Y; Mizutamari H; Mimori N; Kato Y; Fushimi S; Sato S; Okubo S
    Scand J Gastroenterol; 2018 Feb; 53(2):243-251. PubMed ID: 29214885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Effects of Vonoprazan and Lansoprazole for Treating Endoscopic Submucosal Dissection-Induced Artificial Ulcers.
    Hirai A; Takeuchi T; Takahashi Y; Kawaguchi S; Ota K; Harada S; Kojima Y; Tominaga K; Tokioka S; Higuchi K
    Dig Dis Sci; 2018 Apr; 63(4):974-981. PubMed ID: 29464587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vonoprazan is Superior to Rabeprazole for Healing Endoscopic Submucosal Dissection: Induced Ulcers.
    Yamasaki A; Yoshio T; Muramatsu Y; Horiuchi Y; Ishiyama A; Hirasawa T; Tsuchida T; Sasaki Y; Fujisaki J
    Digestion; 2018; 97(2):170-176. PubMed ID: 29310111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of vonoprazan for management of post-endoscopic submucosal dissection ulcers compared with proton pump inhibitors: A meta-analysis.
    Liu C; Feng BC; Zhang Y; Li LX; Zuo XL; Li YQ
    J Dig Dis; 2019 Oct; 20(10):503-511. PubMed ID: 31414725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vonoprazan versus proton-pump inhibitors for gastric endoscopic submucosal dissection-induced ulcers: a systematic review and meta-analysis.
    Jaruvongvanich V; Poonsombudlert K; Ungprasert P
    Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1416-1421. PubMed ID: 29985791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Outcomes of Vonoprazan-Treated Patients after Endoscopic Submucosal Dissection for Gastric Neoplasms: A Prospective Multicenter Observation Study.
    Ishida T; Dohi O; Yamada S; Yasuda T; Yamada N; Tomie A; Tsuji T; Horii Y; Majima A; Horie R; Fukui A; Zen K; Tomatsuri N; Yagi N; Naito Y; Itoh Y
    Digestion; 2021; 102(3):386-396. PubMed ID: 32585678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-related healing of artificial ulcers after endoscopic submucosal dissection using esomeprazole: A randomized controlled study.
    Ko J; Kim SJ; Kang DH; Choi CW; Kim HW; Park SB
    Medicine (Baltimore); 2019 May; 98(20):e15701. PubMed ID: 31096515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of various anti-ulcer medications after gastric endoscopic submucosal dissection: a systematic review and network meta-analysis.
    Kim EH; Park SW; Nam E; Lee JG; Park CH
    Surg Endosc; 2019 Apr; 33(4):1271-1283. PubMed ID: 30167955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vonoprazan versus proton pump inhibitors for the management of gastric endoscopic submucosal dissection-induced artificial ulcer: A systematic review with meta-analysis.
    Kang H; Kim BJ; Choi G; Kim JG
    Medicine (Baltimore); 2019 Jun; 98(24):e15860. PubMed ID: 31192917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vonoprazan versus lansoprazole in the treatment of artificial gastric ulcers after endoscopic submucossal dissection: a randomized, open-label trial.
    Kawai D; Takenaka R; Ishiguro M; Okanoue S; Gotoda T; Kono Y; Takemoto K; Tsugeno H; Fujiki S
    BMC Gastroenterol; 2021 May; 21(1):236. PubMed ID: 34022796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors for Delayed Ulcer Healing after Endoscopic Submucosal Dissection of Gastric Neoplasms.
    Shimozato A; Sasaki M; Ogasawara N; Funaki Y; Ebi M; Tamura Y; Izawa S; Hijikata Y; Yamaguchi Y; Kasugai K
    J Gastrointestin Liver Dis; 2017 Dec; 26(4):363-368. PubMed ID: 29253050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of vonoprazan in prevention of bleeding from endoscopic submucosal dissection-induced gastric ulcers: a prospective randomized phase II study.
    Hamada K; Uedo N; Tonai Y; Arao M; Suzuki S; Iwatsubo T; Kato M; Shichijo S; Yamasaki Y; Matsuura N; Nakahira H; Kanesaka T; Yamamoto S; Akasaka T; Hanaoka N; Takeuchi Y; Higashino K; Ishihara R; Okada H; Iishi H; Fukui K; Shimokawa T
    J Gastroenterol; 2019 Feb; 54(2):122-130. PubMed ID: 29943163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vonoprazan versus proton pump inhibitors for postendoscopic submucosal dissection bleeding in the stomach: a multicenter population-based comparative study.
    Shiratori Y; Niikura R; Ishii N; Ikeya T; Honda T; Hasatani K; Yoshida N; Nishida T; Sumiyoshi T; Kiyotoki S; Arai M; Kawai T; Fukuda K
    Gastrointest Endosc; 2022 Jan; 95(1):72-79.e3. PubMed ID: 34237329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of vonoprazan and proton pump inhibitors for the treatment of gastric endoscopic submucosal dissection-induced ulcer: an updated systematic review and meta-analysis.
    Chen L; Jiang D; Hu D; Cui X
    BMC Gastroenterol; 2024 Mar; 24(1):110. PubMed ID: 38491413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of an ecabet sodium and proton pump inhibitor (PPI) combination therapy with PPI alone in the treatment of endoscopic submucosal dissection (ESD)--induced ulcers in early gastric cancer: prospective randomized study.
    Asakuma Y; Kudo M; Matsui S; Okada M; Kawasaki M; Umehara Y; Ichikawa T; Kitai S
    Hepatogastroenterology; 2009; 56(94-95):1270-3. PubMed ID: 19950775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.